Transcutaneous Vagus Nerve Stimulation on Fibromyalgia- Double-blind, Sham-controlled Randomized Clinical Trial
A legfontosabb adatok
- Ki végzi
- National and Kapodistrian University of Athens
- Hol
- Görögország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 120 fő, tervezett
- Kezdés
- 2024. okt. 15.
- Tervezett befejezés
- 2026. jún. 1.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- tVNS
- A regiszteradat frissítve
- 2025. április 4.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for women with fibromyalgia who have had moderate to high pain for more than 6 months. It tests stimulation of a nerve through the ear (tVNS) alongside standard medicines.
- Életkor
- 18 to 79 years
- Nem
- Women only
- A betegség stádiuma
- Fibromyalgia diagnosed by the ACR 2016 Revised Classification Criteria. Pain above 4 points over 10 for more than 6 months.
A részvétel fő kizáró okai
- Irregular heartbeat (cardiac arrhythmias)
- Pregnancy
- Serious mental disorder, such as bipolar disorder or schizophrenia
- Earlier injury to the vagus nerve, or scar tissue that may get in the way of the stimulation
- An implant that works by electricity or magnets
A regiszter feltételei, szó szerint
Mind a 17 feltétel megnézéseKevesebb
Ki vehet részt
- Women between 18-79 years old
- Women diagnosed with Fibromyalgia according to the ACR 2016 Revised Classification Criteria
- Moderate to high pain intensity according to analog pain scales (above 4 points over 10), for more than 6 months
- Cognitive function sufficient to understand the experiments and follow instructions
- Ability to read and understand all information on the device display
- Ability to adjust the strength of the stimulation or give feedback regarding their response to the device (feeling tingling/pulsating/pain)
- Ability to comply with the recommended therapy regiment of 30 min per day
- The ear electrode needs to fit the patient
- Patients with physical or mental disabilities
- The patient must be able to use the device by themselves or
- The patients' caretaker can operate the device on the patient. In this case the patient --must still be able to give feedback regarding their response to the device
Ki nem vehet részt
- Prior injury to the vagus nerve
- Presence of an electrically or magnetically activated implant
- Cardiac arrhythmias
- Serious mental disorder (dipolar disorder, schizophrenia etc.)
- Pregnancy
- Individuals with scar tissue that may interfere with the stimulation
Nézd meg, megfelelhetsz-e
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 79 év között vagy?
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Stimulation of the vagus nerve, a parasympathetic nerve that controls the digestive, the vascular and immune systems, produces pain relief in various clinical conditions. Transmission via vagal afferents to the nucleus of the solitary tract has been proposed as the primary physiological mechanism that reduces pain intensity following vagal stimulation. Medication is one of the pillars of dealing with chronic pain, with several benefits, but also side effects. Fibromyalgia is an idiopathic chronic pain syndrome with few, effective and safe treatments. However, current research in the field of vagal innervation suggests psychophysiological and electrical ways by which the syndrome may be treated.The chronic pain symptoms of fibromyalgia patients may benefit from vagus nerve stimulation, by normalizing the autonomic and immune system dysfunction that causes their respective symptoms. However, the effects of multiple sessions of transcutaneous vagus nerve stimulation (tVNS) in fibromyalgia have not been evaluated in randomized clinical trials. The hypothesis of our study is to evaluate if the addition of transcutaneous stimulation of the auricular branch of the vagus nerves in patients with fibromyalgia, can lead to better pain control and quality of life. We will offer a 2-week treatment (14 sessions of 30 minutes) in a randomized double-blind controlled trial. The sample of the study, which will be conducted in the pain clinic of the Aretaieion University General Hospital, will be consisted of 120 patients, who will be divided into 2 groups (1st group: standard pharmacological treatment + active tVNS, 2nd group: standard pharmacological treatment + sham tVNS). The study is designed to determine, if standard pharmacological treatment combined with 14 sessions of tVNS is able to improve pain symptomatology in fibromyalgia and all symptoms of this syndrome, by using appropriate scales. This study examines a new and potentially impactful way to address a major public health issue where prevalence is high in given groups, its impact is multidimensional and treatment options are limited. The holistic treatment of chronic pain, including its neurobiological, cognitive, behavioral and psychological components, may become a valuable aid in the completion of the research project, with the ultimate aim of the study being the establishment of non-invasive stimulation of the vagus nerve for the treatment of chronic pain in clinical practice in the future.
A vizsgálat 2 csoportja
- active tVNS groupMár használt kezelés, összehasonlításként
1st group Standard pharmacological Treatment according to EULAR + active tVNS, 30min/session, 7 days/week for 2 weeks (14 sessions total) Regarding the standard pharmacological treatment we will follow a stepwise approach according to the EULAR (European League Against Rheumatism) recommendations. The patients will be randomized by using randomization.org
Kezelés: tVNS
- sham tVNS groupSzínlelt kezelés, összehasonlításként
2nd group Standard pharmacological Treatment according to EULAR + sham tVNS, 30min/session, 7 days/week for 2 weeks (14 sessions total) Regarding the standard pharmacological treatment we will follow a stepwise approach according to the EULAR (European League Against Rheumatism) recommendations. The patients will be randomized by using randomization.org
Kezelés: tVNS
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Investigation of the Effects of Transcutaneous Vagus Nerve Stimulation on Fibromyalgia. A Double Blind, Sham-controlled Randomized Clinical Trial
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Illeszkedési kérdések
- Forrás: NCT06912334: ki vehet részt
- A regiszteradat frissítve
- 2025. április 4.